12th Biennial Symposium of the International Eosinophil Society, Inc. (IES)

国际嗜酸性粒细胞学会 (IES) 第 12 届双年研讨会

• 批准号: 10682801
• 负责人: Steven Jules Ackerman
• 金额: $ 0.7万
• 依托单位: INTERNATIONAL EOSINOPHIL SOCIETY, INC.
• 依托单位国家: 美国
• 财政年份: 2023
• 资助国家: 美国
• 起止时间: 2023-03-06 至 2024-02-29
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10682801
• 关键词: Academy; Address; Alberta province; Allergic; American; Animal Disease Models; Animal Model; Anti-Bacterial Agents; Anti-Inflammatory Agents; Asthma; Autophagocytosis; Award; Basic Science; Belgium; Biochemistry; Biological Response Modifier Therapy; Biology; COVID-19; Canada; Cell Death; Cells; Cellular biology; Chicago; Cities; Clinical; Clinical Investigator; Clinical Research; Clinical Treatment; Clinical Trials; Collaborations; Communities; Consultations; Country; Cutaneous; Cytoprotection; Data; Dermatologic; Development; Diagnostic; Diagnostic tests; Disease; Disseminated eosinophilic collagen disease; Educational workshop; Ensure; Eosinophilic Esophagitis; European; Faculty; Fertilization; Fibrosis; Fostering; Future; Generations; Goals; Health; Health Sciences; Hematology; Homeostasis; Host Defense; Human; Hypersensitivity; Immunity; Immunobiology; Immunology; In Vitro; Infection; Inflammatory; Interdisciplinary Study; International; Leukocytes; Malignant Neoplasms; Mediating; Metabolism; Microbiology; Mission; Molecular; Molecular Biology; Normal tissue morphology; Oral; Organ; Participant; Pathogenesis; Pathology; Pathway interactions; Patients; Pharmaceutical Preparations; Pharmacology; Physiology; Play; Postdoctoral Fellow; Prize; Process; Public Health; Publications; Quebec; Regulation; Research; Research Personnel; Role; Scientist; Series; Societies; Stress; Structure; Subgroup; Sweden; Switzerland; Therapeutic; Translational Research; Underrepresented Minority; United Kingdom; Universities; Viral; Woman; cancer therapy; career; career development; dysbiosis; eosinophil; gastrointestinal; graduate student; gut homeostasis; human disease; improved; in vivo; injury and repair; interest; lectures; meetings; microbiome; neoplastic; new technology; novel; novel strategies; posters; programs; research clinical testing; response; social; sound; symposium; therapeutic target; tissue injury; trafficking; tumor immunology; wound healing

CONFERENCE ABSTRACT R13 conference support is requested for the 12th Biennial Eosinophil Symposium, “Eosinophils 2023”, to be held July 11-15, 2023 at the David Braley Health Sciences Centre, McMaster University, Hamilton, ON, Canada under the auspices of the International Eosinophil Society, Inc. (IES). The meeting hosts ~35 invited speakers and ~120 additional participants who submit abstracts. A cutting-edge program of basic, translational and clinical research is being prepared by the IES Scientific Program Committee in consultation with the Local Organizing Committee. Planned sessions include: 1) regulation of eosinophil development and trafficking, 2) eosinophils in tumor immunology and cancer therapy, 3) eosinophils in tissue injury/repair/fibrosis in organ disease, 4) eosinophil regulation of local immunity and interactions with innate and adaptive cells, 5) cell death (and stress, autophagy) in eosinophil biology, 6) reciprocal interactions between eosinophils and microbiomes in gut homeostasis/dysbiosis, 7) eosinophils in GI diseases, 8) eosinophils in host defense; anti-bacterial and viral responses including COVID-19, 9) eosinophils in dermatologic diseases, 10) novel technologies for studying eosinophils in health and disease, and 11) current status and future of eosinophils as therapeutic targets. The overarching goal is to provide a highly interactive, interdisciplinary forum for scientific exchange amongst junior and established scientists in the fields of allergy, immunology, microbiology, hematology, and cancer in relation to the eosinophil’s roles in health and disease. A primary objective is bringing together basic scientists with expertise in eosinophil biology, and clinician investigators interested in eosinophil-associated diseases, to improve understanding of disease mechanisms, significance of eosinophil functions, and foster translational research. A 2nd objective is to foster the development and interests of younger investigators to help support their career development, creating a new generation of “eosinophiles”. The meeting has a Keystone-like-structure with all participants in a single conference venue for unopposed sessions. Both the scientific and social programs emphasize creating a global community for eosinophil scientists. This meeting is particularly timely because new data and approvals of biologic therapies that directly or indirectly block eosinophil-mediated development and inflammatory pathways are now providing definitive findings on the roles of eosinophils in human health and disease. The symposium, with its strong emphasis on inter-disciplinary research, covers important global diseases including asthma, eosinophilic esophagitis, parasitoses, hypereosinophilic syndromes and COVID-19. The format includes plenary and poster sessions, with the former covering state-of-the-art topics by leaders in the field, followed by cutting edge presentations on recent high impact studies, with oral abstract presentations integrated into the sessions. Two unopposed poster sessions include short presentations of high-impact studies. Two prize lectures are included, the Ehrlich Award for a scientist who has made a major overall contribution to the field, and Gleich Award for a scientist with the highest impact publication over the previous two years.

会议摘要 R13会议支持请求第12届两年一度的嗜酸性粒细胞研讨会，“嗜酸性粒细胞2023”，将举行 2023年7月11日至15日，在加拿大安大略省汉密尔顿麦克马斯特大学大卫布拉利健康科学中心， 由国际嗜酸性粒细胞协会赞助。（IES）。会议邀请了35位演讲者， 约120名额外参与者提交摘要。基础，转化和临床的尖端计划 IES科学计划委员会正在与当地组织协商， 以马克思计划的会议包括：1）嗜酸性粒细胞的发展和运输的调节，2）嗜酸性粒细胞在 肿瘤免疫学和癌症治疗，3）组织损伤/修复/器官疾病纤维化中的嗜酸性粒细胞，4） 嗜酸性粒细胞对局部免疫的调节以及与先天和适应性细胞的相互作用，5）细胞死亡（和应激， 自噬），6）肠道中嗜酸性粒细胞和微生物之间的相互作用 稳态/生态失调，7）胃肠道疾病中的嗜酸性粒细胞，8）宿主防御中的嗜酸性粒细胞;抗细菌和病毒 包括COVID-19在内的反应，9）皮肤病中的嗜酸性粒细胞，10）用于研究的新技术 嗜酸性粒细胞在健康和疾病中的作用，以及11）嗜酸性粒细胞作为治疗靶点的现状和未来。的 总体目标是为青少年科学交流提供一个高度互动的跨学科论坛 过敏、免疫学、微生物学、血液学和癌症领域的知名科学家， 嗜酸性粒细胞在健康和疾病中的作用。一个主要目标是将基础科学家与 嗜酸性粒细胞生物学的专业知识，以及对嗜酸性粒细胞相关疾病感兴趣的临床研究人员， 提高对疾病机制的理解，嗜酸性粒细胞功能的意义，并促进翻译 research.第二个目标是促进年轻研究人员的发展和兴趣，以帮助支持他们的研究。 职业发展，造就新一代的“嗜酸细胞”。会议有一个类似Keystone的结构 所有参与者在一个单独的会议地点进行无反对的会议。科学和社会项目 强调为嗜酸性粒细胞科学家建立一个全球社区。这次会议特别及时，因为 直接或间接阻断嗜酸性粒细胞介导的发展的生物疗法的数据和批准， 炎症途径现在提供了关于嗜酸性粒细胞在人类健康中的作用的明确发现， 疾病研讨会，其重点是跨学科的研究，涵盖重要的全球 疾病包括哮喘、嗜酸性粒细胞性食管炎、寄生虫病、嗜酸性粒细胞增多综合征和COVID-19。 形式包括全体会议和海报会议，前者涵盖了领导人的最新主题， 该领域，其次是最新的高影响力的研究前沿介绍，口头摘要介绍 融入会议。两个无人反对的海报会议包括高影响力研究的简短介绍。 两个奖讲座包括，埃利希奖的科学家谁作出了重大的整体贡献， Gleich奖授予在过去两年中发表影响力最大的科学家。